Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibody-mediated rejection.

Enver Akalin1, Bruno Watschinger

  • 1Renal Division and Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029, USA. enver.akalin@mountsinai.org

Seminars in Nephrology
|July 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation.

Science translational medicine·2026
Same author

Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2026
Same author

Fulminant Acanthamoeba Encephalitis Diagnosed By Cell-Free DNA in a Renal Transplant Patient: A Case Report.

Transplantation proceedings·2026
Same author

Qualified prediction system for allograft failure in real world settings: extended validation study.

BMJ medicine·2026
Same author

Impact of older donor age in kidney transplants in a biopsy-based observational study.

JCI insight·2026
Same author

A New Costimulatory Blockage Agent in the Pipeline.

Transplantation·2026
Same journal

Current Options for Kidney Protection: Are Renin-Angiotensin System Inhibitors Still Relevant?

Seminars in nephrology·2026
Same journal

Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

Seminars in nephrology·2026
Same journal

Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

Seminars in nephrology·2026
Same journal

From Nephron Number to Global Health.

Seminars in nephrology·2026
Same journal

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

Seminars in nephrology·2026
Same journal

Of Diuretics, Transporters, and Mechanisms of Hypertension.

Seminars in nephrology·2026
See all related articles

Antibody-mediated alloimmune responses are crucial in kidney transplantation. Advances in detecting antibodies and C4d staining highlight the incidence and impact of acute and chronic antibody-mediated rejection on graft outcomes.

Area of Science:

  • Nephrology
  • Transplantation immunology
  • Immunopathology

Background:

  • Advances in detecting anti-human leukocyte antigen (HLA) antibodies and C4d staining have revealed the significance of antibody-mediated alloimmune responses in kidney transplantation.
  • Increased transplantation in highly sensitized patients and desensitization protocols have raised awareness and incidence of acute antibody-mediated rejection.
  • Alloantibodies are implicated in chronic rejection, leading to the proposal of chronic antibody-mediated rejection.

Purpose of the Study:

  • To review the current understanding of alloantibodies' role in transplantation.
  • To discuss the diagnosis and treatment strategies for acute and chronic antibody-mediated rejection.
  • To evaluate the impact of antibody-mediated rejection on kidney allograft function and long-term outcomes.

Related Experiment Videos

Main Methods:

  • Review of current literature on antibody-mediated rejection in kidney transplantation.
  • Analysis of diagnostic techniques including C4d staining and single antigen bead flow assays for anti-HLA antibodies.
  • Synthesis of information on treatment protocols for acute and chronic antibody-mediated rejection.

Main Results:

  • Sensitive detection methods have increased the identification of antibody-mediated rejection.
  • Both acute and chronic forms of antibody-mediated rejection significantly affect graft survival.
  • Understanding alloantibody roles is critical for managing transplant outcomes.

Conclusions:

  • Alloantibodies play a pivotal role in both acute and chronic kidney allograft rejection.
  • Early diagnosis and effective management of antibody-mediated rejection are essential for improving graft function and patient outcomes.
  • Further research into alloantibody mechanisms and targeted therapies is warranted.